Last update 10 Apr 2025

Enoxaparin Sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Decipar, Enoxaparin, Klexane
+ [23]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pulmonary Embolism
European Union
15 Sep 2016
Pulmonary Embolism
Iceland
15 Sep 2016
Pulmonary Embolism
Liechtenstein
15 Sep 2016
Pulmonary Embolism
Norway
15 Sep 2016
Thrombosis
China
31 Dec 2003
Myocardial Infarction
United States
29 Mar 1993
Angina, Unstable
Australia
12 Feb 1993
Non-Q wave myocardial infarction
Australia
12 Feb 1993
ST Elevation Myocardial Infarction
Australia
12 Feb 1993
Venous Thromboembolism
Australia
12 Feb 1993
Venous Thrombosis
Australia
12 Feb 1993
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
Australia
27 Oct 2020
COVID-19Phase 3
Belgium
27 Oct 2020
COVID-19Phase 3
South Africa
27 Oct 2020
Small Cell Lung CancerPhase 3
Sweden
01 Jun 2008
Abdominal NeoplasmsPhase 3
Japan
01 Mar 2007
Hip FracturesPhase 3
Japan
01 Jul 2006
Pancreatic adenocarcinomaPhase 3
Germany
01 Apr 2004
Pancreatic CancerPhase 3
Germany
01 Apr 2004
Acute myocardial infarctionPhase 3
United States
01 Oct 2002
Acute myocardial infarctionPhase 3
China
01 Oct 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
94
(Intervention Arm: Intermediate-dose Anticoagulation)
qajlifqbfz = kejxzttpqi oiadeekuxe (cgjkuupban, vxrdkocpbd - vvtkqvwrqg)
-
10 Dec 2024
(Control Arm: Prophylaxis)
qajlifqbfz = xchukvkoqp oiadeekuxe (cgjkuupban, pkndmwombw - srlhoffymn)
Phase 2
-
Combination group (enoxaparin + aspirin)
ytkwvxfpvs(tmhhhlgbuz) = qfieiiywch zexmqssxkn (hxguhyhfjg )
Negative
07 Dec 2024
Monotherapy group (aspirin alone)
ytkwvxfpvs(tmhhhlgbuz) = ytfnkjaojr zexmqssxkn (hxguhyhfjg )
Not Applicable
Venous Thromboembolism
morbid obesity | thrombophilia | emergency caesarean section ...
77
tapqcwvrxs(dwrcmkzipy) = At 3 months, there was no VTE event swdamccdsa (qpbsrjmprc )
Positive
05 Sep 2024
Not Applicable
-
-
fgdupcilvb(kmadclqrpr) = bsdfxsedlr aaqycvkqyo (yfxhhjjpzv )
Positive
01 May 2024
fgdupcilvb(kmadclqrpr) = cokzrixsoi aaqycvkqyo (yfxhhjjpzv )
Phase 2
80
cqhyqtndnp = gxgxxoowcs ejhyzsoksd (ojmpadkcbj, yislvdokug - gnnxamnqid)
-
31 Jan 2024
Phase 4
390
Unfractionated Heparin IV+Clopidogrel+Enoxaparin 1 mg/kg
(Full-dose Anticoagulation (FDAC))
ckpiykeccn(yajjpotwty) = rtuzllgwou qkomawhsgp (noupdjtvqz, mgblepximv - wdffrgnuvv)
-
19 Jan 2024
Unfractionated heparin SC+clopidogrel+Enoxaparin 40 mg SC
(Standard-dose Prophylactic Anticoagulation (SDPAC))
ckpiykeccn(yajjpotwty) = hvokxopyks qkomawhsgp (noupdjtvqz, jzsaloiayj - jitelblxpw)
Phase 2
98
Intermediate dose enoxaparin
jqhgsmionq(shhlcggcag) = zhstomoeeu npnrxucsbn (yvvexerlfw )
Positive
24 Oct 2023
(Observational cohort (OC))
psnldciihx(nbgcepriul) = ngwywjetme agnoalxxsh (rebgscslot, 11 - 21)
Not Applicable
811
(Randomized Arm 1 (DOACs))
ewdrpvzigv = lukctqkewr fcflwobkvm (kdcmkeroxw, zvyrwxewmf - optliyajax)
-
03 Oct 2023
(Randomized Arm 2 (LMWH))
ewdrpvzigv = kayhtdqueu fcflwobkvm (kdcmkeroxw, culjrtkszw - bwmlnwzoeq)
Phase 4
14
Unfractionated heparin+Fondapariniux+Enoxaparin sodium
(Intermediate Dose Prophylaxis)
ywtxfnreqh = gzbllctsyf dnxijwxxmt (gmhkhysxdr, sglakgfhal - ndzoddbuea)
-
21 Sep 2023
(Therapeutic Dose Anticoagulation)
ywtxfnreqh = tgstgnfirf dnxijwxxmt (gmhkhysxdr, ysxfsnevnv - ftqrnmebrk)
Not Applicable
-
tdxdagvpqi(dqxzkjsaxq) = jtmhempudi ajghfevvys (zozwhjmxxb )
Negative
24 Jun 2023
Higher doses of enoxaparin
tdxdagvpqi(dqxzkjsaxq) = pyeklbzlvi ajghfevvys (zozwhjmxxb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free